Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Technologies for Delivery of Proteins, Antibodies and Nucleic Acids market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Technologies for Delivery of Proteins, Antibodies and Nucleic Acidsmarket, defines the market attractiveness level of Technologies for Delivery of Proteins, Antibodies and Nucleic Acids market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Technologies for Delivery of Proteins, Antibodies and Nucleic Acids industry, describes the types of Technologies for Delivery of Proteins, Antibodies and Nucleic Acids market, the applications of major players and the market size, and deeply analyzes the current situation of the global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids market and the development prospects and opportunities of Technologies for Delivery of Proteins, Antibodies and Nucleic Acids industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids market in Chapter 13.
By Player:
Aphios
InnoCore Pharmaceuticals
Camurus
Arbutus Biopharma
LATITUDE Pharmaceuticals
ConjuChem
By Type:
HEPtune Technology
RapidMist
TheraKine Technology
Others
By End-User:
Delivery of Protein
Delivery of Nucleic Acids
Delivery of Antibody
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Analysis and Outlook to 2022
-
7.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Consumption (2017-2022)
-
7.2 United States Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Consumption (2017-2022)
-
7.3 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Consumption (2017-2022)
-
7.4 China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Consumption (2017-2022)
-
7.5 Japan Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Consumption (2017-2022)
-
7.6 India Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Consumption (2017-2022)
-
7.7 South Korea Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Consumption (2017-2022)
8 Region and Country-wise Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Analysis and Outlook to 2028
-
8.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Consumption Forecast (2022-2028)
-
8.2 United States Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Consumption Forecast (2022-2028)
-
8.3 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Consumption Forecast (2022-2028)
-
8.4 China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Consumption Forecast (2022-2028)
-
8.5 Japan Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Consumption Forecast (2022-2028)
-
8.6 India Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Consumption Forecast (2022-2028)
-
8.7 South Korea Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Consumption Forecast (2022-2028)
9 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Outlook by Types and Applications to 2022
-
9.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global HEPtune Technology Consumption and Growth Rate (2017-2022)
-
9.1.2 Global RapidMist Consumption and Growth Rate (2017-2022)
-
9.1.3 Global TheraKine Technology Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Delivery of Protein Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Delivery of Nucleic Acids Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Delivery of Antibody Consumption and Growth Rate (2017-2022)
10 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Outlook by Types and Applications to 2028
-
10.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global HEPtune Technology Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global RapidMist Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global TheraKine Technology Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Delivery of Protein Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Delivery of Nucleic Acids Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Delivery of Antibody Consumption Forecast and Growth Rate (2022-2028)
11 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Import and Export Analysis (Top 5 Countries)
-
11.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Competitive Analysis
-
14.1 Aphios
-
14.1.1 Aphios Company Details
-
14.1.2 Aphios Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Aphios Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product and Service
-
14.2 InnoCore Pharmaceuticals
-
14.2.1 InnoCore Pharmaceuticals Company Details
-
14.2.2 InnoCore Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 InnoCore Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product and Service
-
14.3 Camurus
-
14.3.1 Camurus Company Details
-
14.3.2 Camurus Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Camurus Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product and Service
-
14.4 Arbutus Biopharma
-
14.4.1 Arbutus Biopharma Company Details
-
14.4.2 Arbutus Biopharma Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Arbutus Biopharma Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product and Service
-
14.5 LATITUDE Pharmaceuticals
-
14.5.1 LATITUDE Pharmaceuticals Company Details
-
14.5.2 LATITUDE Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 LATITUDE Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product and Service
-
14.6 ConjuChem
-
14.6.1 ConjuChem Company Details
-
14.6.2 ConjuChem Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 ConjuChem Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Technologies for Delivery of Proteins, Antibodies and Nucleic Acids
-
Figure Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Picture
-
Table Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Consumption by Country (2017-2022)
-
Figure United States Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Consumption and Growth Rate (2017-2022)
-
Table Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Consumption and Growth Rate (2017-2022)
-
Figure China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Consumption and Growth Rate (2017-2022)
-
Figure Japan Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Consumption and Growth Rate (2017-2022)
-
Figure India Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Consumption and Growth Rate (2017-2022)
-
Figure South Korea Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Consumption and Growth Rate (2017-2022)
-
Figure Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Consumption Forecast by Country (2022-2028)
-
Figure United States Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global HEPtune Technology Consumption and Growth Rate (2017-2022)
-
Figure Global RapidMist Consumption and Growth Rate (2017-2022)
-
Figure Global TheraKine Technology Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Delivery of Protein Consumption and Growth Rate (2017-2022)
-
Figure Global Delivery of Nucleic Acids Consumption and Growth Rate (2017-2022)
-
Figure Global Delivery of Antibody Consumption and Growth Rate (2017-2022)
-
Figure Global HEPtune Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global RapidMist Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global TheraKine Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Delivery of Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Delivery of Nucleic Acids Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Delivery of Antibody Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Export by Region (Top 5 Countries) (2017-2028)
-
Table Aphios (Foundation Year, Company Profile and etc.)
-
Table Aphios Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aphios Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product and Service
-
Table InnoCore Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table InnoCore Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Sales, Price, Value and Gross Profit (2017-2022)
-
Table InnoCore Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product and Service
-
Table Camurus (Foundation Year, Company Profile and etc.)
-
Table Camurus Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Sales, Price, Value and Gross Profit (2017-2022)
-
Table Camurus Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product and Service
-
Table Arbutus Biopharma (Foundation Year, Company Profile and etc.)
-
Table Arbutus Biopharma Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Sales, Price, Value and Gross Profit (2017-2022)
-
Table Arbutus Biopharma Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product and Service
-
Table LATITUDE Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table LATITUDE Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Sales, Price, Value and Gross Profit (2017-2022)
-
Table LATITUDE Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product and Service
-
Table ConjuChem (Foundation Year, Company Profile and etc.)
-
Table ConjuChem Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Sales, Price, Value and Gross Profit (2017-2022)
-
Table ConjuChem Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product and Service
-
